lobbying_activities: 2022078

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2022078	d5c2d3d1-e994-40a9-af26-910047b15ca6	Q3	PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION	401103605	PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION	2017	third_quarter	MAN	Lobbied for timely passage of FDA Reauthorization Act (H.R. 2430, S. 934), for changes to proposed OTC Monograph Safety, Innovation and Reform Act of 2017, and for potential solutions to drug shortage situations, and provided general education about the pharma/biopharma contract services sector.	HOUSE OF REPRESENTATIVES,SENATE		60000	0	0	2017-10-11T14:21:46.893000-04:00